Menu
ÚHKT

Impaktované publikace

[1]

Pribyl, M.; Hubackova, S.; Moudra, A.; Vancurova, M.; Polackova, H.; Tomas Stopka, T.; Jonasova, A.; Bokorova, R.; Fuchs, O.; et al.

Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes

[rok vydání 2020, impact factor 6.574 ]

[2]

Jonasova, A.; Bokorova, R.; Polak, J.; Vostry, M.; Kostecka, A.; Hajkova, H.; Neuwirtova, R.; Siskova, M.; Sponerova, D.; Cermak, J.; Mikulenkova, D.; Cervinek, L.; Brezinova, J.; Michalova, K.; Fuchs, O.

High level of full length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide

[rok vydání 2014, impact factor 2.544 ]

[3]

Fuchs, O.; Bokorova, R.

Rationale of targeting protein cereblon as a potential strategy for cancer treatment

[rok vydání 2020, impact factor 0.073 ]

Neimpaktované publikace

[1]

Fuchs, O.; Bokorova, R.

Targeted protein degradation using proteolysis targeting chimeras (PROTACs) in hematologic malignancies

[rok vydání 2020]